Thomas L. Lloyd has been appointed director of automation for the Bioanalytical Group of CEDRA Corp. Mr. Lloyd has more than 22 years of industry experience developing and automating analytical and bioanalytical processes. He has specific expertise in the areas of automation systems and analytical instrument development, bioanalytical chemistry, in vitro DMPK studies, software programming and application, statistics, chemometrics and GLP requirements.

Prior to joining the company, Mr. Lloyd led the automation group at Pfizer, previously as Wyeth Research. He has held previous positions at DuPont Merck Pharmaceutical Co. and GlaxoSmithKline.

“Thomas is an enormous asset to the CEDRA team,” said CEDRA chief executive officer, Anthony G. Busa, Jr. “His extensive industry experience and knowledge in developing and automating analytical and bioanalytical processes are energizing to our team, and his passion for excellence and superior client satisfaction are elevating our offerings to the next level. We are very excited to have him with us and are looking forward to his contributions.”